Titlebook: Universe Unveiled; The Cosmos in My Bub C. V. Vishveshwara Book 2015 Springer International Publishing Switzerland 2015 Astronomy and Cosmo

氣泡

書目名稱Universe Unveiled影響因子(影響力)




書目名稱Universe Unveiled影響因子(影響力)學(xué)科排名




書目名稱Universe Unveiled網(wǎng)絡(luò)公開度




書目名稱Universe Unveiled網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Universe Unveiled被引頻次




書目名稱Universe Unveiled被引頻次學(xué)科排名




書目名稱Universe Unveiled年度引用




書目名稱Universe Unveiled年度引用學(xué)科排名




書目名稱Universe Unveiled讀者反饋




書目名稱Universe Unveiled讀者反饋學(xué)科排名

HEPA-filter

C. V. Vishveshwarasuccesses. In time, most neoplastic cells develop secondary resistance to chemotherapy, which remains the major obstacle to cancer treatment. Progressive multi-drug resistance develops by upregulation of a large family of drug ABC transporters, such as the P-glycoprotein..ALA-PDT is a non-invasive c

Ligneous

C. V. Vishveshwarauring the past three decades, many efforts have been spent to develop strategies to overcome multidrug resistance. Many chemical compounds have been shown to inhibit the drug efflux of the multidrug-resistance-mediating P-glycoprotein. Chemical P-glycoprotein inhibitors are from the classes of calci

prostate-gland

C. V. Vishveshwaradeterioration, and reduced quality of life. At present, there are no targeted therapies solely for brain metastasis, and patients are more likely than not to be excluded from clinical trials evaluating new therapeutic agents. Treatment efforts are hindered by the blood-brain barrier, which prevents

終點(diǎn)

不公開

使長(zhǎng)胖

C. V. VishveshwaraRMM). The advent of targeted therapies has improved the overall survival for MM patients compared to conventional cytotoxic therapies alone. Despite increasing response rates, deeper depths of response, and prolonged survival, MM remains incurable. Almost all patients with MM eventually relapse, sug

corpus-callosum

C. V. Vishveshwarad lead to activated signaling through multiple pro-survival pathways. Clinically, .-ITD mutations confer an increased risk of relapse and diminished overall survival. Clinical responses to monotherapy with first generation type I small molecule FLT3 inhibitors (midostaurin, lestaurtinib) were lacklu

易怒

C. V. Vishveshwaramical and non-chemical control measures to broaden the range of mortality factors and avoid focussing selection pressure on anyone control measure. Chemical countermeasures include:- rotation of unrelated chemical groups on a per generation basis; ovicide/mixtures; mixtures of the bacterial pathogen

樹上結(jié)蜜糖

C. V. Vishveshwaraered in clinical practice, rather than rare presentations.He.This book is designed to assist physicians in the everyday management of hypertensive patients, with a particular focus on difficult-to-treat and resistant hypertension. The selected clinical cases are representative of the patients who ar